TotalSeq™-A0101 anti-human CD335 (NKp46) Antibody, CD335, 9E2,BioLegend,331943
Clone 9E2 has been shown to block NK activation through NKp46.6
Host
Mouse
Reactivity
Human
Application
PG -Quality tested
Platform ID
BAB513021891
BioLegend
Contact
Tel: 1-858-455-9588
Fax: +49 (4131) 7023913
Email:
Product Specifications
Scientific Background
Specifications
NameTotalSeq™-A0101 anti-human CD335 (NKp46) Antibody, CD335, 9E2
Cat. No.331943
HostMouse
RRIDAB_2800875 (BioLegend Cat. No. 331943)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone Number900
Concentration0.5 mg/ml
TargetCD335
ImmunogenNKp46-Fc fusion protein
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-A oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only
Scientific Background
CD335, also known as NKp46, is a member of the natural cytotoxicity receptor (NCR) family which triggers cytotoxicity in NK cells. CD335 is directly involved in target cell recognition and lysis, and is exclusively expressed on CD3-CD56+NK cells, suggesting it is a universal marker for NK cells. NKp46, along with NKp30 and NKp44, is referred to as a natural cytoxicity receptor (NCR) and plays a very important role in killing virus-infected tumor cells and MHC-class I-unprotected cells.
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.